Close menu




May 3rd, 2021 | 07:32 CEST

Steinhoff International, Aspermont, BASF - Things are moving mightily!

  • Investments
Photo credits: pixabay.com

The power of the media as opinion leaders has once again been demonstrated during the Corona Crisis. But the media have changed in recent years. Whereas it used to be enough to announce a "news" item in the daily print edition, nowadays, news outlets are firing from all guns. On social networks like Twitter, YouTube or Facebook, the press is omnipresent and, whether we like it or not, fires us with the most important information throughout the day. The multi-channel strategy will open up new sources of revenue, recently unknown, which will significantly increase the value of companies.

time to read: 3 minutes | Author: Stefan Feulner
ISIN: NL0011375019 , AU000000ASP3 , DE000BASF111

Table of contents:


    Aspermont - Nostalgic data octopus

    No future without online business. The Australian media Company Aspermont has also had to admit this. Based on the two oldest publications for the mining sector, Mining Journal, founded in 1835, and Mining Magazine, the Company launched its digital transformation in 2016 with a five-year plan. More than 7.5 million existing contacts from decision-makers in the mining, energy and agriculture sectors now had to be migrated to the online age and monetized there.

    For generating leads, the Company, headquartered in London, uses algorithms programmed in-house to filter out focal points of interest in a personalized way for the customer based on artificial intelligence. The transformation to a global B2B service provider was completed with "Anything as a Service," i.e., providing services such as news, research, data and live or virtual events. For this, B2B customers pay a monthly flat rate via a subscription model.

    Since 2016, the average annual growth in monthly active users has been 23%. In addition to the subscription business, which is expected to continue growing, Aspermont plans to generate additional brands and products and push for expansion to South America, India and, primarily, China. The Virtual Event & Exhibition division, which was forced to the forefront by the Corona pandemic, was a significant success factor for continued growth. The new division flushed over AUD 1 million into the coffers after just a few months. Overall, the figures for the fourth quarter of 2020 showed enormous growth compared to previous quarters. For example, Q4/2020 and Q1/2021 subscription cash revenues were 22% higher than Q2 and Q3 2020 revenues, realizing cash revenues of AUD 4 million.

    Aspermont is debt-free and has AUD 7 million in cash through a recent successful capital increase. In addition to the free cash flow, which will gradually flow into the new business areas, the management also intends to steadily invest the cash reserves in further growth. Other segments that Aspermont wants to focus on in the future are developing the e-learning and B2B trading platform segments. Aspermont could mutate into a scaling monster through cross-selling effects. The current stock market value is around EUR 40 million. In the long term, this could become "the success story from Down Under."

    Steinhoff International - Subsidiary to help

    An important week for the crisis-ridden Steinhoff shareholders. The South African-German group, which has fallen into disrepute due to the accounting scandal, is looking for sources of income and is now planning to list its subsidiary Pepco on the Warsaw stock exchange. The IPO was initially scheduled for last year but was postponed due to Corona.
    The valuation at Pepco, which operates stores under the "Pepco" and "Dealz" brands in Eastern Europe and under "Poundland" in the UK, is said to be EUR 5 billion. The subsidiary of Steinhoff International operates more than 3200 stores in 16 countries, including more than 1000 in Poland alone. Partly for this reason, the Warsaw trading venue was chosen over the London Stock Exchange. The parent company plans to sell up to 15% of its stake in a first step - a ray of hope for disappointed creditors.

    BASF - Optimism returns

    The chemical group BASF is extremely optimistic about the rest of the financial year. The unexpectedly strong recovery of the global economy and significantly increased raw material prices are the reasons for raising the annual targets.
    The group now expects EBIT adjusted for special items of EUR 5.0 billion to EUR 5.8 billion and sales of EUR 68 billion to EUR 71 billion for the current year. Previously, BASF had planned to achieve an adjusted EBIT of EUR 4.1 billion to EUR 5 billion. For sales, the Company had expected 61 to 64 billion. For global chemical production, management expects annual growth of 5%. Analysts also remained positive on BASF. Thus, both Deutsche Bank and UBS left the share at "Buy."


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Nico Popp on July 1st, 2026 | 07:30 CEST

    Worry-Free Dividends: Best Buy and Unilever Are Turning the Corner—RE Royalties Offers Deep Value and a 10% Dividend

    • royalties
    • dividends
    • Investments
    • renewableenergy

    War or peace? Rarely has the global situation been so chaotic. Even the AI hype, which has driven stock prices higher for years, is fading. So what should investors do? Stable income generators, such as solid dividend stocks, have always been in demand during comparable market phases. But which dividend stock is truly a good choice? While many large corporations are having to reinvent themselves, innovative players in promising niches are shaking up entire markets. A comparison of the three companies—Best Buy, Unilever, and RE Royalties—shows what matters most to dividend investors right now.

    Read

    Commented by André Will-Laudien on June 29th, 2026 | 07:30 CEST

    AI and M&A Frenzy in the Life Sciences Sector: Bayer, Vidac Pharma, Novo Nordisk, Evotec, and Eli Lilly

    • Biotechnology
    • Pharma
    • Biotech
    • AI
    • Investments

    Yes, you read that correctly. Pharmaceutical companies are actively embracing artificial intelligence (AI) and, thanks to lower costs, better validation, and faster study setups, could emerge as winners of the new AI wave in the medium term. Many stocks in the life sciences sector had been overlooked by the market, but investors are now taking notice again. Eli Lilly is betting on AI and expanding its portfolio through targeted acquisitions, including the takeovers of sleep-wake specialist Centessa Pharmaceuticals and blood cancer specialist Ajax. At Evotec and Vidac Pharma, much of the focus is on cancer, while Novo Nordisk faces stiff competition from Eli Lilly's weight-loss drugs. Then came the welcome news regarding Bayer. The Supreme Court ruled that approximately 181,000 individual lawsuits alleging a lack of warning labels on packaging are no longer legally viable, as the US Environmental Protection Agency (EPA) has classified the herbicide glyphosate as safe. Lots of good news, and plenty of opportunities for active investors - we provide a few insights.

    Read

    Commented by Matthias Schomber on June 26th, 2026 | 07:25 CEST

    SAP Testing the Waters, BYD On the Offensive, and MustGrow Biologics Raises Fresh Capital - Is a Rebound on the Horizon?

    • Agriculture
    • mustard
    • agritech
    • biologicals
    • Electromobility
    • Investments
    • Software

    Created and published on behalf of MustGrow Biologics Corp.

    The winds across global equity markets have grown noticeably stronger, bringing sharp moves in both directions. Technology and automotive giants that have long been accustomed to success are feeling the full force of this turbulence. Faced with declining share prices and geopolitical uncertainty, investors are increasingly looking beyond the mainstream for fresh opportunities. While companies such as SAP and BYD are fighting to defend their lofty valuations, intriguing second-tier players are quietly positioning themselves for growth. This raises a legitimate question: should investors allocate capital into "fallen angels" such as SAP and BYD, or focus on lesser-known growth stories with potentially greater upside? We examine the current market environment and take a closer look at three very different companies. Discover why software heavyweight SAP and electric vehicle pioneer BYD are facing challenges, and why Canadian agtech company MustGrow Biologics could be approaching a breakout. One thing is certain: the stage is set for an exciting summer in the markets.

    Read